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Introduction: PET may alter 50% of the radiation gross tumor volume 
(GTV) delineation in comparison with CT targeting in patients with 
NSCLC. Mathematical algorithms (such as the 40% threshold) have 
been used to guide the delineation of the GTV without correlation of 
PET with pathology. Our study had two aims: a) to evaluate/conﬁrm 
the impact of FDG-PET/CT on the GTV delineation by comparison 
with CT without using any speciﬁc mathematical algorithm and b) to 
correlate the CT and PET/CT stages with pathological ﬁndings.
Material and Methods: Thirty-two patients seen between May/2004 
and May/2005 with histologically proven NSCLC with tissue from 
both the mediastinum and primary lung tumor and with pre-treatment 
chest-CT and PET/CT were studied. For each patient two data sets with 
theoretical GTVs were contoured by the same radiation oncologist as if 
they were to receive curative radiation treatment. The 1st contour was 
done based on all available clinical information and the chest-CT only. 
The 2nd contour, done separately, included the fused PET/CT data. 
Two major differences between the GTV contours were deﬁned: 1) 
when there was tumor and/or nodal regions that were included as GTV 
within one data but not the other, and 2) when the difference between 
the GTVs was > 30%. Each patient was staged three times using the 
TNM system: one based on the CT scan only, a second based on the 
PET/CT, and the third based on the pathologic ﬁndings. 
Results: PET altered the TNM stage in 14/32 patients (44%) compared 
to CT, but only 6 of these 14 alterations were conﬁrmed to be accurate 
by pathology. Pathology altered the CT and PET-TNM stages in 69% 
and 53% of the cases, respectively. Concerning the target delineation, 
PET altered the GTV in 18/32 (56%) cases compared to CT: 16 had 
differences in the GTV volume >30% (with or without changes in 
nodal status) and 2 had changes in the nodal status but not in the GTV 
volume. In these 18 cases with altered GTV, 12 had a decrease (range: 
20%-100%) and 6 an increase (4%-237%) of the initial volume. 
Conclusions: Fused PET/CT altered the contour of GTV in over 
50% of patients by comparison with CT targeting, in agreement with 
previously published data, even without any mathematical algorithm. 
However, correlation with pathologic ﬁndings showed that CT and PET 
TNM-stage were incorrect in 69% and 53% of these cases, respectively. 
As has been shown, PET is better than CT to evaluate the extent of the 
disease, but results of PET should ideally be conﬁrmed by pathology. 
With the knowledge we have today it is impossible to accurately dis-
tinguish cancer from non-cancer soft tissue (such as atelectasis) based 
on PET. This factor and the lack of correlation with pathology make 
it difﬁcult to determine the meaning of alterations in volume shown 
in most publications. Whether FDG-PET/CT-based radiation planning 
will improve outcome or quality of life for NSCLC patients remains 
to be determined. (For this study images speak better than words or 
numbers).
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Dose-effect correlation for radiotherapy induced fibrosis using 
Monte Carlo dose calculations and a novel fibrosis image 
segmentation technique.
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Background: Radiation therapy (RT) remains an important therapeutic 
modality in the management of locally advanced non-small cell lung 
cancer (NSCLC). A delicate balance is necessary between maximizing 
dose delivery to the tumor to improve local control and minimizing 
toxicity to surrounding normal vital structures. Methods to accurately 
predict the degree of RT-induced damage are lacking. The purpose of 
this study is to report a new method, developed to evaluate the correla-
tion between RT-induced ﬁbrosis and dose delivered in patients with 
NSCLC.
Methods: Patients with stage IIIA-B NSCLC, uniformly treated on an 
IRB approved prospective phase II trial of combined chemoradiation 
were included in this study. CADPLAN treatment planning system, 
without heterogeneity corrections, was used and the RT dose to the 
target volume was 60 Gy (carboplatin/gemcitabine given neoadjuvantly 
and paclitaxel/gemcitabine given concomitantly wit RT). For each 
patient participating in the study, a computed tomography (CT) simula-
tion scan and several follow-up diagnostic CT scans were acquired. 
Monte Carlo (MC) dose calculations, where the effect of tissue hetero-
geneities was taken into account, were retrospectively performed. Af-
ﬁne registration was used to map follow-up diagnostic CTs to planning 
CT and a new 3-step process was carried out for automatic RT-induced 
ﬁbrosis segmentation. Two approaches were used for the evaluation of 
the correlation between RT-induced ﬁbrosis and dose: (1) correlate phy-
sician-graded ﬁbroses to known dose-volumetric parameters related to 
the risk of RT-induced ﬁbrosis (such as lung volume that receives more 
than 20 Gy [V20], normal tissue complication probability [NTCP], 
and mean lung dose [MLD]) and (2) use the ﬁbrosis volume automati-
cally segmented on the follow-up scans to generate local dose-response 
curves, both over the whole lung volume and over each lung separately.
Results: No correlation could be determined between physician-graded 
ﬁbrosis and the dose-volume parameters used (V20, NTCP, MLD), re-
gardless whether the dose was calculated conventionally (CADPLAN, 
no heterogeneity correction) or using MC (with heterogeneity correc-
tion). However, using our novel ﬁbrosis segmentation method, a dis-
tinct correlation could be seen, on a voxel by voxel basis, between MC 
dose distribution and RT-induced ﬁbrosis: (1) the probability of ﬁbrosis 
monotonically increased as a function of the MC dose and (2) a good 
correlation was observed between the threshold dose derived from the 
differential dose volume histogram and the threshold for the probability 
of ﬁbrosis. No such correlation was observed when doses were calcu-
lated using CADPLAN. RT-induced ﬁbrosis could be detected by the 
automatic segmentation method as early as 20 days and as late as 362 
days after RT completion, irrespective of tumor location or size.
Conclusions: RT-induced ﬁbrosis is a dynamic and very patient-spe-
ciﬁc process that correlates poorly with well-known dose-volume 
parameters. The method described in this paper uses spatio-temporal 
information on RT-induced pulmonary injury and associates it with spa-
